Ken Y. Yoneda, MD

home / authors / ken-y-yoneda-md

Articles

Dr. Yoneda Discusses Pulmonary Nodules

Dr. Yoneda Discusses Pulmonary Nodules

Ken Y. Yoneda, MD
September 23rd 2011

Dr. Ken Y. Yoneda from UC Davis Cancer Center Discusses Pulmonary Nodules

Read More

Dr. Yoneda Discusses Integrating the Pulmonologist

Dr. Yoneda Discusses Integrating the Pulmonologist

Ken Y. Yoneda, MD
September 12th 2011

Dr.Ken Yoneda from UC Davis Cancer Center Discusses Integrating the Pulmonologist into Multidisciplinary Practice

Read More

Dr. Yoneda Describes the Clinical Care Pulmonologist

Dr. Yoneda Describes the Clinical Care Pulmonologist

Ken Y. Yoneda, MD
September 2nd 2011

Dr. Ken Yoneda from the UC Davis Cancer Center Describes the Clinical Care Pulmonologist

Read More

Dr. Yoneda on Advances in the Diagnosis of Lung Cancer

Dr. Yoneda on Advances in the Diagnosis of Lung Cancer

Ken Y. Yoneda, MD
August 26th 2011

Dr. Ken Y. Yoneda from UC Davis Cancer Center on Advances in the Diagnosis of Lung Cancer

Read More

Dr. Yoneda on Bronchoscopy Tools and Procedures

Dr. Yoneda on Bronchoscopy Tools and Procedures

Ken Y. Yoneda, MD
August 24th 2011

Dr. Ken Yoneda from UC Davis Cancer Center Discusses Bronchoscopy Tools and Procedures

Read More

Dr. Yoneda Discusses the Role of the Pulmonologist

Dr. Yoneda Discusses the Role of the Pulmonologist

Ken Y. Yoneda, MD
August 19th 2011

Dr. Ken Yoneda from UC Davis Cancer Center Discusses the Role of the Pulmonologist

Read More

Latest Updated Articles

Arielle Heeke, MD
Published: May 2nd 2025 | Updated: May 6th 2025
Adjuvant CDK4/6 Inhibition Gains Further Ground in HR+/HER2– Early Breast Cancer With Ribociclib Approval
Vivek G Patel, MD
Published: April 2nd 2025 | Updated: May 2nd 2025
Dr Patel on Choosing Between Mosunetuzumab and Epcoritamab in Follicular Lymphoma
Bridging Data and Expert Insights: Paving the Way for Improved CLL Outcomes
Published: March 10th 2025 | Updated: April 25th 2025
Bridging Data and Expert Insights: Paving the Way for Improved CLL Outcomes
Núria Agustí Garcia, MD
Published: April 21st 2025 | Updated: April 23rd 2025
Dr Agustí on Patient Eligibility for Evaluating Chemoradiotherapy vs Radiotherapy Alone in Intermediate-Risk Cervical Cancer
Prognostic and predictive role of circulating tumor DNA (ctDNA) in stage III colon cancer treated with celecoxib: Findings from CALGB (Alliance)/SWOG 80702
Published: April 16th 2025 | Updated: April 18th 2025
Prognostic and Predictive Role of Circulating Tumor DNA (ctDNA) in Stage III Colon Cancer Treated With Celecoxib: Findings from CALGB (Alliance)/SWOG 80702
Genotype-Directed Therapies for HR+/HER2– Advanced Breast Cancer
Published: February 18th 2025 | Updated: April 17th 2025
Genotype-Directed Therapies for HR+/HER2– Advanced Breast Cancer